Recursion Pharmaceuticals, Inc. (RXRX) Earnings
NASDAQ·Healthcare·Biotechnology
$3.43
-1.58%
Mkt Cap $1.57B
Next Earnings
In 5 daysMon, May 4, 2026
EPS Estimate
-$0.27
4 analysts
Revenue Estimate
$17.46M
Last quarter: beat by +25.00% on EPS, +44.04% on revenue.
RXRX reports 2026-05-04 earnings on Monday, May 4, 2026 (5 days from today). Consensus estimates are EPS -$0.27 and revenue $17.46M.
Last quarter, RXRX beat EPS estimates by 25.0% on revenue of $35.35M.
View RXRX earnings dates & historyEPS — Estimate vs Actual
Mkt Cap
$1.57B
P/E
—
Fwd P/E
—
P/S
20.99
Rev TTM
—
EPS TTM
-$1.48